Erich Platzer

Biography

 Dr Erich Platzer is an Investment Advisor and Industry Partner at HBM Partners AG, a venture capital company, which he co-founded in 2001. Further, Dr Platzer acts as a business angel with StartAngels and BioBAC, advising and investing in early-stage companies, in particular in biotech, medtech and high-tech businesses. He has been or is chairman or board member of various publicly traded or privately held biotech companies including Novuspharma, CTI, Micromet, Cylene, mtm laboratories, Nereus, as well as currently Credentis Advanced Osteotomy Tools (AOT), Viroblock and Léman Micro Devices (LMD). Until 1999, Dr Platzer worked for approx. 10 years in various functions in product development and marketing at F. Hoffmann La Roche, Basel, most recently as Business Director Oncology, supervising the therapeutic area of oncology and responsible for various strategic corporate partnerships. Dr Platzer has worked as a physician and researcher for many years and was a member of the team that purified human natural G-CSF (from which Neupogen® was derived). Dr Platzer graduated from the Medical School of the University of Erlangen, where he also received his MDPhD (Dr. med. habil.).

Research Interest

 oncology